Midodrine Arrow (Midodrine Hydrochloride)

Midodrine Hydrochloride, the active ingredient in Midodrine Arrow, is an alpha‑adrenergic agonist presented as an oral formulation for oral use. It raises standing blood pressure in patients who experience orthostatic hypotension, helping to reduce dizziness and fainting episodes associated with the condition.

GNH USA supplies Midodrine Arrow as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Midodrine Arrow is an alpha‑adrenergic agonist used to treat disorders of low blood pressure that occur on standing.

Orthostatic hypotension: improves standing systolic pressure and reduces symptoms of dizziness. Neurogenic orthostatic hypotension: increases vascular tone in patients with autonomic failure, helping maintain cerebral perfusion.

Midodrine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Piloerection (goose‑skin appearance) - Pruritus (itching) - Urinary retention - Supine hypertension - Headache - Nausea

Serious or Rare Side Effects: - Severe hypertension, especially when lying down - Bradycardia or arrhythmia - Ischemic cardiac events - Allergic reactions such as rash or angioedema - Peripheral ischemia leading to tissue damage

Before prescribing Midodrine, clinicians should consider several safety measures. - Blood pressure monitoring: check supine and standing pressures regularly. - Supine positioning: advise patients to avoid lying flat for prolonged periods. - Cardiovascular disease: use caution in patients with coronary artery disease or heart failure. - Renal/hepatic impairment: assess function and adjust therapy if needed. - Contraindicated in pheochromocytoma or severe organic heart disease. - Store at room temperature: keep in the original container, protect from moisture and light.

Midodrine can interact with other medications that affect blood pressure.

Major Interactions (Avoid): - Other alpha‑adrenergic agonists (e.g., phenylephrine) – additive hypertensive effect. - Monoamine oxidase inhibitors – risk of excessive vasoconstriction. - Direct vasopressors (e.g., norepinephrine) – may cause severe hypertension.

Moderate Interactions (Monitor Closely): - Diuretics – may amplify blood pressure changes. - Antihypertensive agents (ACE inhibitors, ARBs, beta‑blockers) – may reduce therapeutic effect. - Tricyclic antidepressants – potential for increased vascular tone.